financetom
Business
financetom
/
Business
/
Meta's WhatsApp down for thousands, Downdetector shows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta's WhatsApp down for thousands, Downdetector shows
Apr 3, 2024 12:11 PM

(Reuters) -Meta Platforms-owned WhatsApp was down for thousands of users on Wednesday, according to outage tracking website Downdetector.com.

There were about 12,000 incidents of U.S. users reporting issues with the messaging platform, according to Downdetector, which tracks outages by collating status reports from a number of sources including user-submitted errors on its platform.

More than 20,000 users in India, about 46,000 in the United Kingdom and over 42,000 in Brazil have also reported problems with the platform, Downdetector data showed.

Around 4,800 people also faced issues with Instagram in the United States, according to Downdetector.

Meta did not immediately respond to a Reuters request for comment.

Last month, hundreds of thousands of users of the social media company's Facebook and Instagram globally were impacted for more than two hours following an outage that was caused by a technical issue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ondas Gets Initial Purchase Order for Iron Drone Raider Systems; Shares Rise
Ondas Gets Initial Purchase Order for Iron Drone Raider Systems; Shares Rise
Jul 22, 2024
10:12 AM EDT, 07/22/2024 (MT Newswires) -- Ondas Holdings ( ONDS ) said Monday a military customer placed an initial purchase order for several Iron Drone Raider counter-drone systems. The company said it expects additional follow-on orders and deployments. Ondas ( ONDS ) shares were up 10.2% in recent trading. Price: 0.93, Change: +0.09, Percent Change: +10.21 ...
TC BioPharm Doses Sixth Person in TCB-008 Trial for Acute Myeloid Leukemia Treatment
TC BioPharm Doses Sixth Person in TCB-008 Trial for Acute Myeloid Leukemia Treatment
Jul 22, 2024
10:12 AM EDT, 07/22/2024 (MT Newswires) -- TC BioPharm ( TCBP ) said Monday it dosed the sixth patient in a trial of TCB-008, a potential treatment for acute myeloid leukemia. The patient got a higher dose after an amendment approved by the UK's Medicines and Healthcare products Regulatory Agency in February, the company said. Five people treated in a...
Truist Financial Second-Quarter Results Fall
Truist Financial Second-Quarter Results Fall
Jul 22, 2024
10:14 AM EDT, 07/22/2024 (MT Newswires) -- Truist Financial's ( TFC ) second-quarter results fell year over year as an accounting gain on the sale of a unit was countered by securities losses. Adjusted earnings dropped to $0.91 a share for the June quarter from $0.92 the year before, but surpassed the Capital IQ-polled consensus for $0.83. On a GAAP...
Atossa Therapeutics Completes Enrollment for 80-Milligram Cohort in Study of Potential Breast Cancer Treatment
Atossa Therapeutics Completes Enrollment for 80-Milligram Cohort in Study of Potential Breast Cancer Treatment
Jul 22, 2024
10:10 AM EDT, 07/22/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Monday that it has completed patient enrollment for the 80-milligram pharmacokinetic run-in cohort of the phase 2 trial of (Z)-endoxifen and exemestane plus goserelin as a treatment for pre-menopausal women with breast cancer. The company said the trial is specifically for grade 1 or 2 estrogen receptor...
Copyright 2023-2026 - www.financetom.com All Rights Reserved